Table 2.
Test | Definition | Hemostatic phase | Cause for abnormalities | Intervention | Studies on the use of viscoelastic tests after pediatric trauma | ||
---|---|---|---|---|---|---|---|
TEG® Assay time: 10-15 min | RoTEM® Assay time: 5-10 min | TEG® | RoTEM® | ||||
R | CT | Time from initiation of test until the beginning of the clot formation | Initiation of coagulation | Prolonged R/CT: -Factor deficiencies -Anticoagulants Short R/CT: -Plasma hypercoagulability |
Plasma | Admission rapid TEG results correlate with conventional coag tests and predict early transfusion, early LSI and outcome. [58] Report on TEG guided hemostatic resuscitation [135] | Age related reference ranges established in children [61] Report on Successful RoTEM-guided Hemostatic therapy after blunt trauma. [80] |
K | CFT | Time from start of the clot formation to the curves reaches amplitude of 20 mm | Amplification of coagulation | Prolonged K/CFT: -Factor deficiencies -Hypofibrinogenaemia -Thrombocytopenia -Platelet dysfunction |
Cryoprecipitate | ||
α | α | Angle between baseline and the tangent to the curve through the starting point of coagulation | Propagation of coagulation ‘Thrombin burst’ | Low α -Factor deficiencies -Hypofibrinogenaemia -Thrombocytopenia -Platelet dysfunction |
Cryoprecipitate | ||
MA | MCF | Amplitude measured at max curve width | Low MA/MCF -Hypofibrinogenaemia -Thrombocytopenia -Platelet dysfunction -FXIII deficiency |
Platelets (consider FXIII concentrate if ongoing bleeding and persistently low MA/MCF) | |||
LY | ML | Reduction in area under curve (LY) or in amplitude (ML) from the time MA/MCF is achieved until 30 or 60 min after MA/MCF | Fibrinolysis | Increased LY/ML - Hyperfibrinolysis |
Antifibrinolytics |
Table modified from [136]